APA (7th ed.) Citation

Calogera Butera, Ilaria Cetta, Roberta Messina, Laura Zanandrea, Roberto Santangelo, Bruno Colombo, . . . Ubaldo Del Carro. (2024). Efficacy and safety of anti-CGRP monoclonal antibodies for chronic migraine prophylaxis in patients treated with botulinum toxin A: A prospective monocentric study. SAGE Publishing.

Chicago Style (17th ed.) Citation

Calogera Butera, Ilaria Cetta, Roberta Messina, Laura Zanandrea, Roberto Santangelo, Bruno Colombo, Massimo Filippi, and Ubaldo Del Carro. Efficacy and Safety of Anti-CGRP Monoclonal Antibodies for Chronic Migraine Prophylaxis in Patients Treated with Botulinum Toxin A: A Prospective Monocentric Study. SAGE Publishing, 2024.

MLA (9th ed.) Citation

Calogera Butera, et al. Efficacy and Safety of Anti-CGRP Monoclonal Antibodies for Chronic Migraine Prophylaxis in Patients Treated with Botulinum Toxin A: A Prospective Monocentric Study. SAGE Publishing, 2024.